- Trials with a EudraCT protocol (37)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
37 result(s) found for: Sense of Agency.
Displaying page 1 of 2.
EudraCT Number: 2021-000267-72 | Sponsor Protocol Number: D3252C00002 | Start Date*: 2021-09-07 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study of Benralizumab in Patients with Eosinophilic Chronic Rhinosinusitis with Nasal Polyps ... | ||
Medical condition: Patient with Eosinophilic Chronic Rhinosinusitis with Nasal Polyps | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Trial now transitioned) HU (Trial now transitioned) PL (Trial now transitioned) IT (Ongoing) SE (Ongoing) BG (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004583-22 | Sponsor Protocol Number: 548.12 | Start Date*: 2012-10-20 | |||||||||||
Sponsor Name:OSPEDALE PEDIATRICO BAMBINO GESU' DI ROMA | |||||||||||||
Full Title: Verification of the effectiveness of intravenous sildenafil compared to other pulmonary vasodilators used in the test vessel reactivity of pulmonary | |||||||||||||
Medical condition: Subjects in children with congenital heart disease surgery or not, with echocardiographic signs of pulmonary hypertension followed at the Pediatric Cardiology Centre of the Mediterranean or reporte... | |||||||||||||
|
|||||||||||||
Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000750-13 | Sponsor Protocol Number: 1218.40 | Start Date*: 2008-06-30 |
Sponsor Name:Boehringer Ingelheim Finland Ky | ||
Full Title: A 78 week open label extension to trials assessing the safety and efficacy of BI 1356 (5 mg) as monotherapy or in combination with other antidiabetic medications in type 2 diabetic patients. | ||
Medical condition: Patients with type 2 Diabetes Mellitus. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) NL (Completed) SE (Completed) AT (Completed) SK (Completed) DE (Completed) ES (Completed) GB (Completed) CZ (Completed) BE (Completed) HU (Completed) IT (Completed) GR (Completed) PT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-003596-46 | Sponsor Protocol Number: 942/08 | Start Date*: 2009-02-25 | ||||||||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | ||||||||||||||||||
Full Title: Multicenter, not-for-profit clinical study, in a open, controlled, randomized fashion to compare tolerability, safety and efficacy of two different treatment strategies for non malignant, persisten... | ||||||||||||||||||
Medical condition: non neoplastic cronic pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001833-16 | Sponsor Protocol Number: PROTOCOLLO NPDEP0106 | Start Date*: 2006-07-13 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Multicentric, no-profit, open, controlled randomized clinical study to evaluate comparable tolerability and efficacy of two pharmacological treatments for persistent, non oncological pain in the el... | |||||||||||||
Medical condition: persistent non oncological pain | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001459-35 | Sponsor Protocol Number: MC/PR/1400/007/11 | Start Date*: 2012-12-20 | |||||||||||
Sponsor Name:CHIESI | |||||||||||||
Full Title: MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED STUDY ON THE THERAPEUTIC EFFICACY AND SAFETY OF BECLOMETHASONE DIPROPIONATE SUSPENSION FOR INHALATION 800 micrograms TWICE... | |||||||||||||
Medical condition: Acute rhinosinusitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000579-40 | Sponsor Protocol Number: D1443L00002 | Start Date*: 2007-10-10 | |||||||||||
Sponsor Name:Charité Universitätsmedizin Berlin | |||||||||||||
Full Title: Effects of atypical versus typical neuroleptics on motivation, hedonia, and social cognition in patients with schizophrenia – an fMRI study | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003101-42 | Sponsor Protocol Number: EFC14146 | Start Date*: 2016-11-18 | |||||||||||
Sponsor Name:SANOFI-AVENTIS RECHERCHE ET DEVELOPPEMENT | |||||||||||||
Full Title: A Randomized, 24-Week Treatment, Double-blind, Placebo-controlled Efficacy and Safety Study of Dupilumab Every Other Week, in Patients with Bilateral Nasal Polyposis on a Background Therapy with In... | |||||||||||||
Medical condition: nasal polyps | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) DE (Completed) NL (Completed) CZ (Completed) FR (Completed) PL (Completed) BG (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003036-30 | Sponsor Protocol Number: MRZ 60201-0607/1 | Start Date*: 2007-03-08 | |||||||||||
Sponsor Name:Merz Pharmaceuticals GmbH | |||||||||||||
Full Title: Ensaio clínico prospectivo, randomizado, de observador cego, com grupos paralelos e multicêntrico, para avaliar a eficácia e a segurança de duas diluições diferentes de NT 201 em pacientes com espa... | |||||||||||||
Medical condition: Chronic upper limb spasticity caused by diverse etiologies | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) DE (Completed) GB (Completed) AT (Completed) FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000344-21 | Sponsor Protocol Number: MP1032-CT05 | Start Date*: 2021-06-24 | ||||||||||||||||||||||||||
Sponsor Name:MetrioPharm AG | ||||||||||||||||||||||||||||
Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PROOF-OF-CONCEPT, PHASE IIA STUDY OF MP1032 PLUS STANDARD OF CARE VS STANDARD OF CARE IN THE TREATMENT OF HOSPITALIZED PATIENTS WITH MOD... | ||||||||||||||||||||||||||||
Medical condition: Moderate to severe coronavirus disease 2019 (COVID 19) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: HU (Completed) ES (Ongoing) BG (Completed) IT (Ongoing) RO (Ongoing) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-004977-42 | Sponsor Protocol Number: CB-01-11/28 | Start Date*: 2017-11-10 | |||||||||||
Sponsor Name:Cosmo Technologies Ltd. | |||||||||||||
Full Title: A Phase II, multicentre, randomised, double-blind, placebo controlled, proof of concept study of efficacy and safety of Rifamycin SV-MMX® 600 mg tablets administered three or two times daily to pat... | |||||||||||||
Medical condition: Diarrhoea-predominant irritable bowel syndrome (IBS-D) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) ES (Temporarily Halted) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003151-21 | Sponsor Protocol Number: INT 35/06 | Start Date*: 2006-08-31 | |||||||||||
Sponsor Name:ISTITUTO NAZIONALE PER LA CURA TUMORI | |||||||||||||
Full Title: Study to compare the tolerability of slow release oxycodone versus slow release morphine in the treatment of severe cancer pain. The study is geared towards a clinical practice improvement. | |||||||||||||
Medical condition: Advanced cancer patient with severe cancer pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003176-12 | Sponsor Protocol Number: A-93-52030-279 | Start Date*: 2014-08-27 | |||||||||||
Sponsor Name:IPSEN S.p.A | |||||||||||||
Full Title: A PHASE II, MULTICENTRE, RANDOMIZED CONTROLLED STUDY EVALUATING THE QUALITY OF LIFE IN PATIENTS WITH INOPERABLE MALIGNANT BOWEL OBSTRUCTION TREATED WITH LANREOTIDE AUTOGEL 120 MG IN COMBINATION WIT... | |||||||||||||
Medical condition: Inoperable malignant bowel obstruction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000944-41 | Sponsor Protocol Number: FenS-FenD | Start Date*: 2015-04-20 | |||||||||||
Sponsor Name:FONDAZIONE IRCCS "ISTITUTO NAZIONALE DEI TUMORI" | |||||||||||||
Full Title: A PILOT STUDY TO TEST THE FEASIBILITY OF A TWO-ARM, DOUBLE BLIND, PARALLEL-GROUP, RANDOMIZED CONTROLLED TRIAL FOR THE COMPARISON OF THE DURATION OF THE ANALGESIC EFFICACY OF A SINGLE MATRIX TRANSDE... | |||||||||||||
Medical condition: Patients with oncological pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007938-21 | Sponsor Protocol Number: 1245.24 | Start Date*: 2009-03-30 | |||||||||||
Sponsor Name:Boehringer Ingelheim GmbH&Co KG | |||||||||||||
Full Title: A 78 week open label extension to trials assessing the safety and efficacy of BI 10773 as monotherapy or in combination with Metformin in type 2 diabetic patients. | |||||||||||||
Medical condition: Diabetes type 2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) SK (Completed) SE (Completed) DE (Completed) EE (Completed) FR (Completed) AT (Completed) ES (Completed) CZ (Completed) LT (Completed) HU (Completed) LV (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000829-27 | Sponsor Protocol Number: LPS16747 | Start Date*: 2021-07-30 | |||||||||||
Sponsor Name:Sanofi-aventis Recherche & Développement | |||||||||||||
Full Title: A randomized, double-blind, head-to-head comparison of dupilumab versus omalizumab in severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and comorbid asthma patients | |||||||||||||
Medical condition: Chronic rhinosinusitis with nasal polyps | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) BE (Ongoing) CZ (Ongoing) FI (Ongoing) HU (Ongoing) SE (Ongoing) ES (Ongoing) DK (Ongoing) PT (Ongoing) PL (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004812-40 | Sponsor Protocol Number: D2211C00001 | Start Date*: 2012-01-26 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A phase IIa, randomised, double-blind, placebo-controlled, parallel-arm, multicenter study to evaluate the efficacy and safety of tralokinumab (CAT-354), a recombinant human monoclonal antibody dir... | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) NL (Prematurely Ended) CZ (Completed) IT (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003567-10 | Sponsor Protocol Number: 217023 | Start Date*: 2021-12-23 | |||||||||||
Sponsor Name:GLAXOSMITHKLINE BIOLOGICALS | |||||||||||||
Full Title: A phase 2, single-blinded, randomised, controlled multi-country study to evaluate the safety, reactogenicity, efficacy and immune response following sequential treatment with an anti-sense oligonuc... | |||||||||||||
Medical condition: Hepatitis B virus (HBV) infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) BE (Trial now transitioned) FR (Ongoing) DE (Trial now transitioned) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001042-10 | Sponsor Protocol Number: VX16-150-102 | Start Date*: 2018-01-17 | ||||||||||||||||
Sponsor Name:Vertex Pharmaceuticals Incorporated | ||||||||||||||||||
Full Title: A Phase 2, Randomized, Double-blind, Placebo-controlled, 6-Week, Parallel-design Study of the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy | ||||||||||||||||||
Medical condition: Pain Caused by Small Fiber Neuropathy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) NL (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-004888-31 | Sponsor Protocol Number: OXN3508 | Start Date*: 2015-01-26 | |||||||||||
Sponsor Name:Mundipharma Research GmbH & Co. KG | |||||||||||||
Full Title: A randomised, double-blind, double-dummy, cross-over multicenter study to demonstrate equivalence in analgesic efficacy and bowel function taking oxycodone equivalents of 120 and 160 mg per day as ... | |||||||||||||
Medical condition: The intended indication is: Chronic severe non malignant pain, chronic severe malignant pain, requiring opioids. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.